Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Lifetime Data Analysis|January 1, 1997
Nonparametric tests for comparing two mean residual life functionsE E AlyAnaesthesia|January 17, 2007
Anaesthetic management of uncontrolled idiopathic intracranial hypertension during labour and delivery using an intrathecal catheterE E Aly, B K LawtherExpert Opinion on Drug Delivery|August 21, 2015
Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrierAmirah E-E Aly, Barbara L WaszczakActa Anaesthesiologica Scandinavica|April 25, 2009
Endotoxin-like reaction following once-daily gentamicinE E Aly, S K Sivasubramaniam, T H Bhatti, et al.Molecular Neurobiology|May 21, 2018
Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's DiseaseAmirah E-E Aly, Brendan T Harmon, Linas Padegimas, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|November 26, 2018
Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brainAmirah E-E Aly, Brendan Harmon, Linas Padegimas, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2023
Focused ultrasound enhances transgene expression of intranasal hGDNF DNA nanoparticles in the sonicated brain regionsAmirah E-E Aly, Tao Sun, Yongzhi Zhang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2023
Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisksAmirah E-E Aly, Nicholas S Caron, Hailey Findlay Black, et al.Translational Neurodegeneration|October 8, 2024
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease miceNicholas S Caron, Lauren M Byrne, Fanny L Lemarié, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington diseaseNicholas S Caron, Amirah E-E Aly, Hailey Findlay Black, et al.Pageof 1